Changes in survival during the past two decades for breast cancer at the Kyoto University Hospital

European Journal of Surgical Oncology

Volumn 33, Issue 6, 2007, Pages 696-699

  Ueno, M ^a,b   Kiba, T ^a   Nishimura, T ^a   Kitano, T ^a   Yanagihara, K ^a   Yoshikawa, K ^a   Ishiguro, H ^a   Teramukai, S ^a   Fukushima, M ^a   Kato, H ^b   Inamoto, T ^b  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Breast cancer; Chronological change; Survival rates

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; CYCLOPHOSPHAMIDE; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; GONADORELIN AGONIST; METHOTREXATE; TAMOXIFEN; TAXANE DERIVATIVE; TOREMIFENE; TRASTUZUMAB;

ADJUVANT THERAPY; ADULT; ARTICLE; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; HUMAN; JAPAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; UNIVERSITY HOSPITAL;

ADULT; AGE FACTORS; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; JAPAN; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; RECEPTORS, ESTROGEN; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34447091909     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.01.029     Document Type: Article

References (15)

1. Yoshimoto M., Tada K., Hori H., et al. Improvement in the prognosis of Japanese breast cancer patients from 1946 to 2001 - an institutional review. Jpn J Clin Oncol 34 (2004) 457-462
2. Bonnier P., Romain S., Charpin C., et al. Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features. Int J Cancer 62 (1995) 138-144
3. Yildirim E., Dalgic T., and Berberoglu U. Prognostic significance of young age in breast cancer. J Surg Oncol 74 (2000) 267-272
4. La Rosa F., Patavino V.M., Epifani A.C., et al. Ten-year survival and age at diagnosis of women with breast cancer from a population-based study in Umbria, Italy. Tumori 82 (1996) 441-443
5. Barchielli A., and Balzi D. Age at diagnosis, extent of disease and breast cancer survival: a population-based study in Florence, Italy. Tumori 86 (2000) 119-123
6. Taylor R., and Coates M. Breast cancer five-year survival in New South Wales women, 1972 to 1991. Aust N Z J Public Health 21 (1997) 199-205
7. Zahl P.H., and Tretli S. Long-term survival of breast cancer in Norway by age and clinical stage. Stat Med 16 (1997) 1435-1449
8. Ugnat A.M., Xie L., Morriss J., Semenciw R., and Mao Y. Survival of women with breast cancer in Ottawa, Canada: variation with age, stage, histology, grade and treatment. Br J Cancer 90 (2004) 1138-1143
9. De Laurentiis M., Gallo C., De Placido S., et al. A predictive index of axillary nodal involvement in operable breast cancer. Br J Cancer 73 (1996) 1241-1247
10. Korkolis D.P., Tsoli E., Fouskakis D., et al. Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients. Anticancer Res 24 (2004) 2061-2068
11. Sobin L.H., and Wittekind C.H. TNM classification of malignant tumors. 6th ed. (2002), Wiley-Liss, New York 131-141
12. http://www.oncoconferences.ch/2005/home/home.htm
13. Sant M., and Gatta G. The EUROCARE database (1995), IARC Scientific Publications, Lyon
14. Brinkley D., and Haybittle J.L. The curability of breast cancer. Lancet ii (1975) 95-97
15. Easson E.C., and Russell M.H. The curability of cancer in various sites (1968), Pitman, London